Decision letter for "Cytomegalovirus-based viral vectors elicit robust systemic and tissue-resident immune response against SARS-CoV-2 antigens"

2026

View at publisher
DOI: 10.1002/eji.70146/v3/decision1
Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses Virus-based gene therapy research

Publication details

Publication date
27 January 2026